Jan 17 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX GRANTED PATENTS FOR ONCOS-102 IN COMBINATION WITH
CHEMOTHERAPY IN CHINA AND JAPAN
* PATENT PROTECTION IN CHINA AND JAPAN FOR ONCOS-102 IN
COMBINATION WITH CHEMOTHERAPY IN MALIGNANT MESOTHELIOMA
* PATENTS COVER USE OF ONCOS-102 IN COMBINATION WITH
CHEMOTHERAPY
IN MALIGNANT MESOTHELIOMA.
* US FDA GRANTED ONCOS-102 FAST TRACK DESIGNATION FOR MPM IN
FEBRUARY 2021 BASED ON ENCOURAGING PRE-CLINICAL AND CLINICAL
DATA PACKAGE
Source text for Eikon: ID:nObixJ1lta
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))